Inventor
WALTERS IAIN
GB27 patents
⚠️ This page may combine multiple inventors who share the name “WALTERS IAIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CORCEPT THERAPEUTICS INC
15 patentsUS10047082B2Aug 14, 2018
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC40 citations97
US9956216B2May 1, 2018
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC40 citations97
US9707223B2Jul 18, 2017
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC44 citations97
US9273047B2Mar 1, 2016
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC66 citations97
US8859774B2Oct 14, 2014
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC67 citations97
US10973813B2Apr 13, 2021
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC16 citations94
US10456392B2Oct 29, 2019
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC25 citations94
US10787449B2Sep 29, 2020
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC11 citations93
US10323034B2Jun 18, 2019
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC20 citations93
US11648245B2May 16, 2023
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC4 citations85
US11576907B2Feb 14, 2023
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC6 citations85
US11560379B2Jan 24, 2023
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC6 citations85
US11370789B2Jun 28, 2022
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC8 citations85
US12139486B2Nov 12, 2024
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC0 citations62
US12226412B2Feb 18, 2025
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC0 citations52
RESPIVERT LTD
6 patentsUS10294216B2May 21, 2019
Pyrazolyl ureas as kinase inhibitors
RESPIVERT LTD1 citations72
US11208381B2Dec 28, 2021
Indole derivatives and their use as protein kinase inhibitors
RESPIVERT LTD2 citations70
US10669235B2Jun 2, 2020
Indole derivatives and their use as protein kinase inhibitors
RESPIVERT LTD2 citations70
US11142515B2Oct 12, 2021
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD0 citations61
US9884845B2Feb 6, 2018
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD1 citations61
US11046672B2Jun 29, 2021
Indolinones compounds and their use in the treatment of fibrotic diseases
RESPIVERT LTD0 citations46
ASTRAZENECA AB
5 patentsUS6875868B2Apr 5, 2005
Pteridine compounds for the treatment of psoriasis
ASTRAZENECA AB41 citations89
US7071193B2Jul 4, 2006
7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases
ASTRAZENECA AB11 citations84
US6958344B2Oct 25, 2005
Pyrimidine compounds and their use as modulators of chemokine receptor activity
ASTRAZENECA AB19 citations82
US6958343B2Oct 25, 2005
Thiazolopyrimidines and their use as modulators of chemokine receptor activity
ASTRAZENECA AB13 citations81
US7329686B2Feb 12, 2008
Substituted thiophene compounds
ASTRAZENECA AB0 citations40